Mark Mendonca
3Patents
1h-index
10Co-inventors
37Inventor score
Filing activity: Jul 20, 2017 → Jan 20, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10562968B2 | Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof | Emerging Cross-Sectional Technologies | 4 | Active |
| US11685777B2 | Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11884722B2 | Anti-GPRC5D antibodies, bispecific antigen binding molecules that bind GPRC5D and CD3, and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.